πŸ‡ΊπŸ‡Έ FDA
Patent

US 6828299

Polyhydroxy glycopeptide derivatives

expired A61KA61K47/40A61K47/6951

Quick answer

US patent 6828299 (Polyhydroxy glycopeptide derivatives) held by Theravance, Inc. expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K47/40, A61K47/6951, A61K9/0014, A61K9/0019